Aileron proposes $69M IPO

On June 2, stapled peptide therapeutics company Aileron Therapeutics Inc. (Cambridge, Mass.) proposed to raise $69 million in an IPO on NASDAQ underwritten by BofA Merrill Lynch, Jefferies, William B...